Ebola Fears: Drug And Suit Makers Up In The Market

Boston, MA 10/13/2014 (wallstreetpr) – The Ebola menace is slowly finding its way in the U.S. after a nurse who cared for an Ebola patient was also diagnosed with the virus. Companies developing cures for the diseases lead by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have been on an upward swing. Focus […]

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) And Other Ebola Drug Providers Jump High After Positive Test for Ebola in a Health Care Worker

Boston, MA 10/13/2014 (wallstreetpr) – A few days back, when US officials found two Ebola infected people in Texas, questions on country’s preparations to take on one of the deadliest diseases of the world started raising. Although US government said that it was prepared for Ebola, but things might not be that easy. As per […]

Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)

Boston, MA 10/07/2014 (wallstreetpr) – Pharma firm Alcobra Ltd (NASDAQ:ADHD) announced on 6th October that its phase three tests on its drug candidate Metadoxine to treat Attention Deficit Hyperactivity Disorder. The drug maker announced that the results have indicated that the “extended release” approach of administering the drug to adults which is being experimented has […]

Bill Gates Provides His Views As Fight Against Ebola Intensifies While Strong Reliance On Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)’s TKM-Ebola

Boston, MA 10/04/2014 (wallstreetpr) – In an interview with NBC’s ‘Meet the Press,’ Dr. Tom Frieden, who is the Director of the Centers for Disease Control and Prevention, speaks on the Ebola issue and the availability of drugs for same, while companies like Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) are involved in coming up with a cure […]

Investors Eye Sumptuous Retuns From BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX’s) Recent Endeavors

Boston, MA 10/06/2014 (wallstreetpr) – BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) revealed in a declarative statement that the prestigious National Institute of Allergy and Infectious Diseases, dubbed as NIAID, has aptly practiced two options that provides manufacture of the product – BCX4430 and another GMP drug substance. If these options are duly exercised, it would lead to a […]

Can Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) Sustain The Recent Spike Or Its Just Ebola Effect?

Boston, MA 10/03/2014 (wallstreetpr) – Hundreds of people died due to Ebola over the past few months in Arabian and African Countries. Many companies tried to come up with a permanent solution of this virus without any success. Ebola is once again in news, so is Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR). As soon as two fresh cases of […]

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)’s RNAi Based Therapeutic Approach To Fight Ebola Outbreak

Boston, MA 09/24/2014 (wallstreetpr) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has joined a global consortium to conduct an RNA interference (RNAi) pivotal treatment against Ebola in West Africa. Prioritized RNAi Therapeutics According to a Globe Newswire article, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), which is a leading developer of RNAi treatment methods, announced the news of the collaboration yesterday. […]

Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola

Boston, MA 08/18/2014 (wallstreetpr) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has gained investor’s attention after the announcement of the development of experimental treatment that can get rid of the deathly virus Ebola. As soon as TKMR made this announcement, investors showed a lot of interest in trading options on it. When Did It Start? Ebola has […]

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) Witnessed 22% Shares Drop; As Ebola Frenzy Cools Down

Boston, MA 08/13/2014 (wallstreetpr) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) on August 12, 2014 lost approximately 22% of the overall value, in the backdrop of treatment for Ebola virus, which continues to haunt the world at present. Drug Makers Scrambling to hunt Ebola Virus Treatment It must also be noted that Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) is among those […]

FDA Paves The Way For Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)’s Ebola Drug

Boston, MA 08/08/2014 (wallstreetpr) – After a long wait, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)’s drug for Ebola has received the official nod from the U.S. regulators. It can now be used on infected patients. Previously, FDA had put the tests of the drug termed as TKM-Ebola on hold.  Now, it has received the partial hold status […]

Tuesday Shakers: Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), Plug Power Inc (NASDAQ:PLUG), SMART Technologies Inc (NASDAQ:SMT)

Boston, MA 03/25/2014 (wallstreetpr) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) hopes to zero in with a medical solution in a market segment where many developers have shied away from. The company is developing Ebola medication and this month the U.S. Food and Drug Administration – FDA, granted fast-track designation to its drug candidate targeting Ebola virus. The […]

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) Rated as a Hold

Boston, MA 03/06/2014 (wallstreetpr) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) which is a biopharmaceutical company that specializes in the research and development of RNA interference is currently rated as a “Hold” by TheStreet. The biopharmaceutical company controls a market cap of $412 million with a 30 day share moving average of 288,300. Its key strengths can […]